The Reimbursement Code Your Medtech Startup Is Counting On Doesn't Exist Yet
Most medtech founders assume a CPT or ICD code will be waiting when they're ready to sell. Here's why that assumption will wreck your commercial timeline.
W. Osei Topic
commercialization
14 posts tagged commercialization from Lab to Launch.
W. Osei More on commercialization
The Reference Customer You're About to Name in Your Pitch Deck Is Going to Call You a Liar
Before you put a customer logo in your pitch deck, understand exactly what that relationship actually means and what they'll say when investors call.
W. OseiThe Data Package Your Potential Acquirer Requested Is a Fishing Expedition
When a big company asks for your technical data package, they're not always serious buyers. Here's how to tell the difference and protect yourself.
W. OseiThe Strategic Partnership MOU Your Fortune 500 Contact Sent You Is a Stall Tactic
That MOU from a big corporate partner feels like validation, but it's often a delay mechanism. Here's how to tell the difference and what to do about it.
W. OseiThe Non-Disclosure Agreement Your Potential Partner Sent You Is a Trap
That NDA from your potential industry partner looks standard. It probably isn't. Here's what deep tech founders miss before they sign.
W. OseiThe Clinical Advisor You Just Recruited Has No Idea How to Get You Paid
Your clinical advisor is brilliant and respected. But if they can't talk reimbursement codes, they may be the most expensive hire you never paid for.
W. OseiThe Prototype You Built in the Lab Is Not a Product and Never Will Be
Your lab prototype proves the science works. It proves almost nothing about whether you can build a real product. Here's what changes between bench and shelf.
W. OseiThe Pilot Agreement That Will Trap You Inside a Single Customer Forever
That pilot deal with your first big customer feels like validation. It might actually be the contract that kills your startup's growth before it starts.
W. OseiThe Accelerator Program That Will Waste Six Months of Your Runway
Not every accelerator is built for deep tech founders. Here's how to tell which ones will drain your runway instead of building your company.
W. OseiWhy Your First Licensing Deal Will Cost You More Than You Made
Licensing your deep tech looks like free money, until the audits, sublicensing traps, and milestone clawbacks hit. Here's what to watch.
W. OseiWhy Your Grant-Funded Proof of Concept Is Lying to You
Grant funding lets you control every variable. That's exactly why your proof-of-concept data may be telling you a story that doesn't survive first contact with a real market.
W. OseiHow to Pitch Deep Tech to Non-Technical Investors Without Losing Your Soul
Technical founders often tank investor pitches by over-explaining the science. Here's how to translate your research into language that closes rounds.
W. OseiWhy Your First FDA Meeting Will Feel Like Academic Hazing
What biotech founders really face in their first FDA pre-submission meeting and how to survive the regulatory reality check.
W. OseiWhy Your First Manufacturing Partner Will Ghost You (And How to Prevent It)
Technical founders face brutal reality when manufacturers suddenly stop responding, here's why it happens and how to avoid it.
W. Osei Browse more topics